Fast-paced tumor replication requires high levels of iron uptake, thus TfRC is often over-expressed in breast, gastric, colon cancer and glioblastoma [10] and has therefore prompted the use of TRC as a target for anti-cancer therapy [11]. The gene discussed is TFRC; the disease is neoplasm.